Legal & Verdicts
Jury Awards $50 Million in Johnson & Johnson Talc Mesothelioma Case
A jury awarded $50 million to the family of a woman who developed mesothelioma after decades of using Johnson & Johnson talcum powder products. The...
Expert reporting on treatment advances, legal developments, research breakthroughs, and resources for mesothelioma patients and families.
The combination of nivolumab and ipilimumab (Opdivo + Yervoy) continues to demonstrate superior overall survival compared to chemotherapy for patients with unresectable malignant pleural...
A jury awarded $50 million to the family of a woman who developed mesothelioma after decades of using Johnson & Johnson talcum powder products. The...
Researchers have identified a panel of four protein biomarkers in blood samples that can detect malignant pleural mesothelioma with 92% sensitivity...
The U.S. Mineral Products Company Asbestos Personal Injury Settlement Trust has reopened for new claim submissions after a 6-month administrative...
The Department of Veterans Affairs has expanded presumptive service connection for mesothelioma, meaning veterans diagnosed with this cancer no...
When retired Houston Ship Channel shipyard worker Roberto Martinez was diagnosed with pleural mesothelioma at age 71, his family faced an...
Tumor Treating Fields (TTFields), a wearable medical device that uses alternating electric fields to disrupt cancer cell division, has demonstrated a...
Asbestos bankruptcy trust funds have collectively paid out more than $20 billion to victims of asbestos exposure since the first trusts were...